Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Informed consent

• Subjects aged 18 and older

• Glaucoma patients and healthy controls

• Best corrected visual acuity \>0.1

• Astigmatism ≤ 3dpt.

• Good compliance

• Central corneal thickness (400-650μm)

• Passed certification procedure (detailed description under: Measurements and procedures)

• Therapeutic regimen unchanged throughout the past 30 days

Locations
Other Locations
Switzerland
Cantonal Hospital of Lucerne
RECRUITING
Lucerne
Contact Information
Primary
Raphael Fritsche, MD
raphael.fritsche@luks.ch
0041 205 33 76
Time Frame
Start Date: 2020-11-26
Estimated Completion Date: 2024-08-01
Participants
Target number of participants: 25
Treatments
Experimental: icare HOME
Related Therapeutic Areas
Sponsors
Leads: Luzerner Kantonsspital

This content was sourced from clinicaltrials.gov